I. Filimonova

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific T Cells and Antibodies in Coronavirus Disease 2019 (COVID-19) Protection: A Prospective Study

Elizaveta V. Romanova, G. Efimov, D. Logunov, 2022, Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America.

Exhaustive Search of the Receptor Ligands by the CyCLOPS (Cytometry Cell-Labeling Operable Phage Screening) Technique

A. Belogurov, Y. Lomakin, M. Zakharova, 2020, International journal of molecular sciences.

Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides

Alexander V. Favorov, V. Vlassov, O. Favorova, 2020, Frontiers in Immunology.

Reprogramming Extracellular Vesicles for Protein Therapeutics Delivery

S. Terekhov, R. Ziganshin, A. Zalevsky, 2021, Pharmaceutics.

A prospective study of the protective effect of SARS-CoV-2-specific antibodies and T cells in Moscow residents

A. Mohammad, N. Pinegina, A. Deryabin, 2021, medRxiv.